Gapping down
In reaction to earnings/guidance:
- GPS -9.9% (also names new CEO of Banana Republic), FRO -7%, PSTG -4.6%, AEO -2.8%, VMW -1.1%, CCC -0.9%
Other news:
- NKLA -14.6% (CEO Mark Russell said on Mad Money that talks are still ongoing between GM (GM) for fuel technology system; CNBC reporting that both sides can walk away if deal is not finalized by next week)
- LQDA -8.1% (receives complete response letter from FDA for LIQ861 inhalation powder for the treatment of pulmonary arterial hypertension)
- RETA -6.7% (provides update on omaveloxolone program)
- EVOP -3.1% (stock offering)
- JKS -2.5% (announced the resignation of Zhiqun Xu as the Chief Operating Officer and the appointment of Dr. Jiun-Hua Allen Guo as the new Chief Operating Officer)
- UROV -2.4% (announces top-line data from Phase 2a study of vibegron; study did not meet primary endpoint)
- MCF -1.8% (stock offering)
- AAL -1.1% (MESA enters into new contract with AAL to operate 40 CRJ-900s)
Analyst comments:
- GOOS -4.3% (downgraded to Sell from Buy at BTIG Research)
- CZR -3% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- GRBK -2.9% (downgraded to Neutral from Buy at BTIG Research)
- FSLY -2.2% (downgraded to Neutral from Outperform at Credit Suisse)
- F -1.4% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- FNB -1.2% (downgraded to Equal-Weight from Overweight at Stephens)
- DRI -1% (downgraded to Neutral from Buy at BTIG Research)